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Specialty Update
What’s New in Spine Surgery
Keith H. Bridwell, MD, Paul A. Anderson, MD, Scott D. Boden, MD, Alexander R. Vaccaro, MD, PhD, and Jeffrey C. Wang, MD
What’s New in the Treatment of the Cervical Spine
Diagnostic Evaluation
The Spurling test is performed to test the irritability of a cer-
vical nerve root by hyperextending the neck and compressing
downward, which, when positive, reproduces a specific der-
matomal pain pattern. Based on the gold standard of computed
tomography (CT) or magnetic resonance imaging (MRI), this
simple test has high sensitivity (95%) and specificity (95%) for
identifying nerve root compression.
Evaluation of the cervical spine in patients with blunt
trauma remains controversial. Clearing the spine in asymp-
tomatic patients with normal mentation and no distracting
injuries on the basis of National Emergency X-Radiography
Utilization Study (NEXUS) clinical criteria without radio-
graphs was questioned by investigators in Virginia. In a three-
year study, the investigators found that twenty-five of 2606
patients had fractures that were missed when cervical spines
were cleared with use of the NEXUS criteria. Two fractures
required surgery, and one required halo-vest treatment.
Clearing the cervical spine in the obtunded patient is more
difficult, and CT and other modalities are often recommended.
A meta-analysis involving >14,000 patients in which CT alone
was compared with CT plus another modality demonstrated
that CT alone had 99.9% sensitivity and specificity and a 100%
negative predictive value. The authors concluded that CT alone
is adequate to clear the cervical spine in obtunded patients.
The use of CT for clearing the cervical spine is not
without risk. Low-dose ionizing radiation, such as diagnostic
CT, can induce neoplasia. The thyroid has the highest growing
incidence of cancer and is particularly sensitive to radiation.
Furthermore, females and children have increased sensitivity of
the thyroid to radiation. Muchow et al. evaluated 617 children
with level-1 or 2 trauma who had CTor radiographs for cervical
spine clearance. The radiation dose and the excess relative risk
of cancer induction were calculated, with CT having sixty times
higher radiation exposure than radiographs. The excessive
lifetime thyroid cancer risk of a single CT was increased 25%
for females and 13% for males. The authors concluded that this
risk needs to be considered when ordering CT imaging for
pediatric patients.
Disc Arthroplasty
The results of five cervical disc arthroplasty trials with five-year
follow-up have been reported. The studies showed equal or
better clinical outcomes compared with those following ante-
rior discectomy and fusion for single-level radiculopathy and
myelopathy. The reoperation rates at the index intervertebral
disc level generally were equivalent to those following fusion.
There was variation in the reoperation rates at adjacent levels,
with some studies showing equivalency and others favoring
arthroplasty over fusion. Failures due to loosening or inflam-
matory reactions to wear debris have been reported as small
case reports, with an incidence of <1% in randomized trials.
Outcomes
The measurement of patient satisfaction on the basis of
meeting patient expectations is becoming increasingly utilized
and will become an important measure of the quality of care.
In cervical and lumbar spine surgery, meeting expectations is
associated with greater satisfaction and better functional out-
comes. However, higher preoperative patient expectations are
associated with lower satisfaction, despite these patients having
better outcomes. Discussion of expectations during the in-
formed consent process based on patient preferences is im-
portant to maximize satisfaction.
Posterior Surgery
The use of recombinant human bone morphogenetic protein-2
(rhBMP-2) for posterior cervical surgery is not approved by the
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U.S. Food and Drug Administration (FDA), but this ‘‘off-label’’
use has been reported to produce excellent fusion rates.
However, safety has been questioned. In a large retrospective
cohort study of adults with degenerative disc conditions, in-
vestigators found no differences in terms of complications
(including wound drainage and infection) but found that pa-
tients had more chronic neck pain. In a large case series of
forty-five children who were managed with upper cervical
spine fusion with rhBMP-2, five patients developed seroma
(two of whom required emergency drainage because of ob-
structive hydrocephalus) and one patient developed hypertro-
phic bone formation and compression of the cervicomedullary
junction.
Cervical Myelopathy
The best treatment for cervical spinal stenosis in asymptomatic
or mildly affected patients is unknown. A randomized con-
trolled trial comparing nonoperative with operative treatment
showed no difference in outcomes between these two groups at
ten years of follow-up. The authors were unable to predict
which patients in the nonoperative treatment group would
develop progressive neurologic deficits. Additional guidelines
by The Japanese Orthopaedic Association do not support
prophylactic surgery for patients with ossification of the pos-
terior longitudinal ligament associated with absent or only
mild symptoms. Furthermore, no association between the se-
verity of ossification of the longitudinal ligament and the risk of
spinal cord injury has been identified.
Neuroprotection with use of antiglutamatergic, antioxi-
dant, or antiapoptotic strategies are being used and tested with
the aim of slowing degeneration of the central nervous system
associated with amyotrophic lateral sclerosis. Similar agents are
being studied for the treatment of cervical myelopathy. In a
phase-1 and 2a trial, granulocyte colony-stimulating factor
(5 and 10 mcg/kg/day) was administered to patients with
progressive cervical myelopathy. All patients had improvement,
and no adverse events were reported. A new trial of riluzole, a
sodium-glutamate blocker that has neuroprotective actions,
is being planned to reduce the chance of neurologic deterio-
ration and to enhance recovery in patients undergoing surgery
for the treatment of myelopathy due to cervical spine disease.
What’s New in Biologic Topics for the Spine
In 2011, biologics continued to be a major focus in spine re-
search for the treatment of spinal disorders. The majority of
clinical attention in the past year focused on the frequency
of rhBMP-2-related complications and the potential under-
reporting of such complications in the original clinical trials. In
addition, laboratory efforts continue to investigate the role of
biologics in retarding or reversing intervertebral disc degen-
eration and in facilitating disc tissue engineering strategies. The
use of autogenous iliac crest bone graft continues to decline,
and the use of biologics is on the rise. Recent surveys have
estimated that BMPs were used in >50% of spine fusion pro-
cedures and that >80% of that use was physician-directed (off-
label) as this use is not approved by the FDA.
Recombinant Osteoinductive Proteins
A primary concern with physician-directed use of recombinant
BMPs continues to focus on local adverse events. The most
commonly reported local side effects are heterotopic bone
formation in the surgical approach track, transient radiculitis,
transient vertebral body bone resorption when used near ex-
posed cancellous bone, and sterile seroma fluid collections and/
or local edema. Most of these local side effects are believed to be
related to the use of excessive BMP by surgeons, either through
increasing the concentration of the growth factor or through
overstuffing the defect, which can result in a higher concen-
tration or leakage of BMP into surrounding tissues. These side
effects mostly occur three to seven days following surgery, with
the exception of cancellous bone resorption, which is evident at
three to six months and can persist beyond one year.
In June 2011, a series of articles, editorials, press re-
leases, and letters to the editor alleged that major safety risks
from rhBMP-2 were under-reported in original studies that
were largely co-authored by consultants from the product’s
sponsor. In the months that followed, numerous articles were
published in an attempt to address some of the issues that had
been raised in relation to rhBMP-2-related complications.
Many of the original complications were reported in associ-
ation with off-label use of rhBMP-2 for anterior cervical
discectomy and fusion. Although the authors of the original
FDA pilot study, which involved a very low dose of rhBMP-2,
did not report complications of local edema, seromas, airway
obstruction, and dysphagia, subsequent reports involving
unspecified and often much higher doses continued to
highlight these issues, which appear to be largely (although
not entirely) related to the use of excessive rhBMP-2 doses in
the anterior cervical spine.
The three main allegations in June 2011 were that (1)
rhBMP-2 increased the rate of retrograde ejaculation when
used for anterior lumbar interbody fusion (the FDA-approved
indication), (2) rhBMP-2 resulted in increased radiculitis when
used for posterior spinal fusion, and (3) rhBMP-2 was asso-
ciated with a higher cancer incidence. Whether rhBMP-2 in-
creases the incidence of retrograde ejaculation is still not clear,
although an alternative explanation seems to be related to
surgical exposure (transperitoneal versus retroperitoneal) and
surgical technique. More studies are due out shortly to address
this issue more definitively.
The issue of radiculitis, presumably due to neuro-
inflammation, was raised on the basis of a reanalysis of rela-
tively small clinical trials. Two recent large database studies
(including one involving >55,000 patients from the Scoliosis
Research Society [SRS] database and one involving >15,000
patients from the Medicare database) demonstrated no in-
crease in overall complications, wound infection, or hema-
toma/seroma for thoracic or lumbar deformity surgery and
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single-level lumbar fusions. Seromas do occasionally occur in
association with the use of rhBMP-2 for posterior spine fusion
and can result in dural compression if not detected early. An-
other issue recently has been raised on the basis of a rodent
spinal cord injury model that showed that rhBMP-2 penetrated
the spinal cord and resulted in potentially detrimental in-
flammatory changes. A clinical review of >1000 patients re-
ceiving rhBMP-2 revealed a dural tear in the lumbar spine in
5.6% of the patients, but none of those patients experienced
new postoperative radiculopathy, so the effect on lumbar and
peripheral nerves may be different from the effects on the
spinal cord. Local side effects related to rhBMP-2 typically
occur at least two to five days after implantation.
Perhaps the most concerning issue raised is the potential
association between rhBMP-2 and cancer. The approved for-
mulation of 6 to 12 mg of rhBMP-2 delivered on an absorbable
collagen sponge (ACS) was not associated with an increased
incidence risk of cancer on the basis of the manufacturer’s
analysis of all spine clinical trial data, although an external
analysis of publicly available data, which may be incomplete,
led to a different conclusion. The larger question remains on
the yet-to-be-approved higher dose formulation, which would
be 40 mg of rhBMP-2 delivered on a biphasic ceramic collagen
sponge. A recent review of 93,000 lumbar fusion patients in
the Medicare database showed no increased risk of pancreatic
cancer with use of BMP.
Another unanswered question associated with rhBMP-2
is whether repeat exposure will compromise efficacy due to
antibody generation. Fewer than 10% of patients who are
managed with rhBMP-2 develop antibodies transiently, and
none have been neutralizing. A study of second rhBMP-2 ex-
posure in a rabbit spine fusion model did not show any di-
minished efficacy of rhBMP-2.
Other Bone Graft Substitutes
Although much focus remains on recombinant osteoinductive
proteins, their relatively high cost has continued to encourage
research involving other bone graft solutions. Demineralized
bone matrix continues to be utilized for spine fusion. A small
prospective, randomized trial showed that Grafton DBM
(Demineralized Bone Matrix) with local bone had fusion rates
comparable with those associated with autogenous iliac crest
bone graft.
Biologic Treatments for Intervertebral Disc Degeneration
Progress toward biologic treatments to prevent or retard in-
tervertebral disc degeneration or to heal anular defects con-
tinues at a slow pace. Trials of OP-1 (osteogenic protein-1) and
GDF-5 (growth differentiation factor-5) are reportedly under
way, but no results have been published to date. Tissue engi-
neering strategies involving the use of chondrocytes or mes-
enchymal stem cells (MSCs) on collagen, hydrogel, biphasic
silk composite, and gellan gum-based microparticle/hydrogel
matrices are all being investigated. One study suggested that
transplanted MSCs seemed to be an acceptable substitute for
nucleus pulposus cells in a rabbit model of intervertebral disc
degeneration.
Realistically, the use of biologics to treat disc degenera-
tion is a long way from clinical application, but it remains
worth monitoring developments in this area, which could ul-
timately become a disruptive technology for the treatment and
prevention of many degenerative spine disorders.
What’s New in Spinal Deformity Surgery
One hundred and sixteen papers were presented from the
podium at the annual meeting of the Scoliosis Research Society,
which was held from September 14 to 17, 2011 in Louisville,
Kentucky.
Idiopathic Scoliosis
Current studies have suggested that all-screw constructs lead to
a decrease in thoracic kyphosis and an increase in proximal
junctional kyphosis. It is not clear how much of the problem is
the utilization of only screws as opposed to the maneuvers
being performed. The most common maneuver is pushing
down on the convex apical screws to derotate the spine. Al-
though this may provide some derotation, it reduces thoracic
kyphosis. The reported prevalence of proximal junctional
kyphosis has ranged from 5% to 15%.
There is also renewed interest in the impact of sagittal
correction of the thoracic spine on both the cervical and
lumbar spine. The hypokyphotic thoracic spine will often
present with a somewhat hypolordotic cervical and lumbar
spine. If a component of thoracic kyphosis is surgically dialed
into the correction maneuver for the thoracic curve, the sur-
geon will often observe more cervical and lumbar lordosis. Is
this producing favorable lordosis or unfavorable compensatory
hyperextension?
One multicenter prospective study analyzed improve-
ment in pulmonary function at two years after scoliosis surgery.
The authors observed greater absolute and percentage im-
provement in forced expiratory volume in one second (FEV-1)
and forced vital capacity (FVC) for impaired patients as com-
pared with normal controls (p < 0.002), but the absolute and
percent predicted pulmonary function values for the impaired
patients still lagged behind those for the normal controls (70%
versus 85% predicted; p < 0.0001) in spite of similar correction
in curve magnitude in coronal and sagittal planes.
Adult Spinal Deformity
At least one study suggested the use of hooks at the top of the
construct appeared to reduce proximal junctional kyphosis, to
some extent, when compared with the use of screws as the
proximal anchor for adult spinal deformity surgery. In spite of
a prevalence of proximal junctional kyphosis of as high as 22%
in one study, it appears that, in most cases, if the proximal
junctional kyphosis is mild, there are no significant differences
in SRS or Oswestry Disability Index (ODI) scores between
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proximal junctional kyphosis compared with non-proximal
junctional kyphosis patients.
One multicenter study assessed the prevalence and cause
of symptomatic rod fractures following posterior spinal fusion
with instrumentation for the treatment of adult spinal defor-
mity. The authors found a high prevalence of early rod fractures
in patients having pedicle subtraction osteotomy, particularly
if not performed through a prior fusion mass.
On the basis of several studies, it is clear that revision
surgery for the treatment of adult spinal deformity will result in
a high complication rate and that the rate of additional surgery
after revision may be as high as 20%. Furthermore, a higher
complication rate should be expected in patients over the age of
sixty years as compared with younger patients, but it appears
that the benefit in terms of improvement in SRS and ODI
scores in patients over the age of sixty years is identical to that in
patients under the age of sixty years.
Growing Rod/Growing Spine Techniques
One study that was presented at the annual meeting of the SRS
compared the effect of early fusion for the treatment of early-
onset scoliosis with the effect of treatment with a dual growing
rod system for several years. The authors found that spine
elongation throughout treatment and the lung space that was
gained between the preoperative and postoperative periods
were significantly less in the early fusion group. Proximal
junctional kyphosis is a substantial problem associated with
distraction-based growing rods. The authors of one study
quoted a prevalence of 56% and stated that proximal junc-
tional kyphosis was twice as common with dual rods as
compared with single rods. The authors of another study
suggested that serial casting is a viable alternative to surgical
techniques in patients with moderate to severe early-onset
scoliosis and reported that 74% of their cohort of patients
who were managed with serial casts avoided surgery for an
average of 3.1 years.
Three-Column Osteotomy
Many reports have substantiated the high blood loss associated
with three-column surgical procedures and also the high
prevalence of neuromonitoring changes during the procedures.
Neuromonitoring changes often result in changes in surgical
strategies. Most neurologic catastrophes can be avoided if
neuromonitoring potentials improve with maneuvers such as
reducing the degree of correction, enhancing temporary sta-
bilization of the spine, and raising blood pressure and poten-
tially transfusing the patient with blood.
Neuromuscular Deformities
For patients with cerebral palsy, it would appear that the
Caregiver Priorities and Child Health Index of Life with Dis-
abilities (CPCHILD) questionnaire is a meaningful outcome
measure of the effectiveness of surgical treatment of spinal
deformity in children with severe cerebral palsy.
Miscellaneous Topics
One biomechanical study of human cadaver spines showed that
anterior release generated more potential for thoracic derota-
tion than Ponte osteotomy did. To some extent, that goes
against the clinical trend of performing more Ponte osteot-
omies and fewer anterior releases.
At least one study on the surgical treatment of high-grade
lytic dysplastic spondylolisthesis demonstrated that aggressive
reduction did not improve the fusion rate, increased neurologic
complications, and resulted in a higher reoperation rate. It is
clear that patients with high-grade spondylolisthesis present
with poorer SRS scores in the presence of positive sagittal
balance.
What’s New in Spinal Cord Injury
Early Versus Delayed Surgery for Spinal Cord Injury
The potential benefit of early spinal cord decompression in pa-
tients with spinal cord injury has long been a topic of interest,
and there is ample evidence in the basic science literature sup-
porting the benefit of early decompression in rat, feline, canine,
and primate models of spinal cord injury. The Surgical Treat-
ment of Acute Spinal Cord Injury Study (STASCIS) has been
completed, and early results specifically evaluating the timing
of surgery in patients with cervical spinal cord injury were
presented at the meeting of the Cervical Spine Research Society
in December 2011. One hundred and thirty-five patients who
underwent early decompression less than twenty-four hours
(average, 14.2 hours) after the injury were compared with
ninety-six patients who underwent delayed decompression more
than twenty-four hours (average, 48.4 hours) after the injury.
Early surgery performed at less than twenty-four hours after the
injury resulted in a significant increase in the likelihood of a
2-grade improvement in the American Spinal Injury Association
(ASIA) Impairment Scale (AIS), with an associated odds ratio of
2.6. After adjustment for preoperative neurologic status and
steroid administration, this odds ratio increased to 2.8. While
these results are encouraging, longer follow-up will more de-
finitively characterize the benefit of early intervention in patients
with traumatic spinal cord injury.
Translational Research
Basic science research into neuronal regeneration and recovery
continues to spawn clinical studies investigating the safety and
efficacy of pharmacologic and biologic treatments for patients
with spinal cord injury. Although animal models of spinal cord
injury often demonstrate promising results, the jump from
rodent models to human trials reveals fundamental differences
between animals and humans in terms of the regenerative ca-
pacity and plasticity of the spinal cord. Nonetheless, many
treatments that have shown potential in preclinical studies are
currently under investigation for human use.
Oligodendrocyte progenitor cells attracted attention as a
potential therapeutic biologic intervention under the premise
that remyelination of injured but structurally intact axons
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could improve recovery. After animal models demonstrated
improved recovery of locomotion after implantation of these
cells, Geron (Menlo Park, California) initiated a human clinical
trial of oligodendrocyte progenitor cells (GRNOPC1) (clin-
icaltrials.gov identifier NCT01217008). The trial was halted by
the FDA in 2007 because of concerns about local cyst formation
at the injection site and then was resumed in 2010. Despite
great excitement in the regenerative medicine community,
the trial was halted in November 2011 because of a funding
shortage, unrelated to any adverse events, according to state-
ments from Geron executives. There are no other ongoing
studies utilizing human stem cells for patients with spinal cord
injury in the United States.
A trial utilizing purified human neural stem cells in pa-
tients with ASIA grade-A injuries was recently initiated in
Switzerland by StemCells (Newark, California) and will be
watched closely as the only ongoing trial using cellular therapy,
but data are not yet available (clinicaltrials.gov identifier
NCT01321333). Finally, Neuralstem (Rockville, Maryland) has
submitted an application to begin a human trial of use of hu-
man spinal cord stem cells for patients with spinal cord injury
but is still awaiting approval.
Myelin inhibits neurite growth, and several myelin pro-
teins have potent in vivo ability to inhibit functional neuronal
recovery, including Nogo-A, a transmembrane protein. After
primate models of incomplete spinal cord injury demonstrated
greater functional recovery in animals treated with an anti-
Nogo antibody, a human phase-I clinical study was undertaken
by Novartis (Basel, Switzerland) with intrathecal administra-
tion of an anti-Nogo antibody known as ATI355 (clinical-
trials.gov identifier NCT00406016). Enrollment in the study
was completed in September 2011 with a total of fifty-two
patients, although no results have been released.
Riluzole is a sodium channel blocker that is thought to
prevent spinal cord injury through the prevention of cytotoxicity
related to increasing calcium concentration and presynaptic re-
lease of glutamate. Riluzole has been shown to be beneficial in
preclinical spinal cord injury models and is additionally attrac-
tive as a potential treatment for spinal cord injury because it
is already FDA-approved as a therapy for amyotrophic lateral
sclerosis (ALS), for which patients take it indefinitely. On the
basis of these factors, a phase-I clinical trial was initiated in April
2010 and completed enrollment of thirty-six patients in June
2011 (clinicaltrials.gov identifier NCT00876889). Patients who
were enrolled in the study were managed with riluzole at a dose
of 50 mg/day for fourteen days, half the typical dose given to
patients with ALS and for a much shorter period of time. Results
from this trial have not been released.
What’s New in the Treatment of the Lumbar Spine
Lumbar spinal pathology stills persists as one of the leading
musculoskeletal issues that plague patients. Recent studies that
were presented over the past year have demonstrated ad-
vancements in treatments.
Vertebral Augmentation
Vertebral augmentation for compression fractures remains a topic
of interest. Over the past year, several studies continued to explore
the merits of this procedure. One study examined the hospital
outcomes of vertebroplasty, kyphoplasty, and nonoperative treat-
ment for vertebral compression fractures with use of a national
healthcare database that included data on 20% of all inpatient
hospitalizations in the United States. This study included patients
with both neoplastic disease (86,810 patients) and non-neoplastic
disease (370,933 patients). After adjusting for covariates, the ver-
tebral augmentation group had a significantly higher likelihood of
routine discharge to home and a lower risk of discharge to a skilled
nursing facility in comparison with the nonoperative treatment
group. The patients in the operative treatment group also had a
lower risk of in-hospital mortality, pressure ulcer formation,
pneumonia, and infection as compared with those in the non-
operative treatment group. The operative treatment group had a
higher risk of surgical complications and medical care. The only
surgical difference between vertebroplasty and kyphoplasty was the
rate of infection, which was lower in the kyphoplasty group.
Another multicenter prospective randomized trial com-
pared kyphoplasty with nonoperative management for patients
with neoplastic disease. This study included 134 patients who
were followed for a minimum of one year. The patients in the
operative treatment group showed significant improvement in
all Short Form-36 (SF-36) subscales at the one-month period.
After one month, 59% of patients in the nonoperative treat-
ment group crossed over into the operative treatment group.
Patients who remained in the nonoperative treatment group
did not improve. The average increase in vertebral height was
3.1 mm at the one-year follow-up time point. The authors
concluded that patients with cancer-related vertebral com-
pression fractures that were treated with kyphoplasty showed
significant improvements in terms of quality of life at one
month as compared with nonoperatively managed patients.
Another group of authors presented a meta-analysis of
randomized and nonrandomized controlled studies comparing
kyphoplasty, vertebroplasty, and nonoperative management.
Twenty-seven of 1539 studies met the inclusion criteria. The
studies included patients with osteoporotic compression frac-
tures. The results showed significant pain reduction in associa-
tion with operative intervention, with no differences between the
two procedures. There was a higher risk of subsequent fracture
and less improvement in terms of disability in the nonoperative
treatment group. Kyphoplasty demonstrated superiority over
vertebroplasty in terms of improvement in quality of life, the rate
of cement extravasation, vertebral body height restoration, and
kyphotic angle correction. The authors concluded that operative
treatment was superior to nonoperative treatment in terms of
pain reduction and the rate of subsequent vertebral fractures.
Complications of Sexual Dysfunction
Several recent studies focused on complications, and one fo-
cused on the problem of erectile dysfunction in patients with
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spinal disease. A prospective study examined the prevalence of
erectile dysfunction in patients under the age of fifty years with
non-fracture-related lumbar spine disease requiring operative
decompression. None of the sixty-one patients in the study had
any other known risk factors for this problem. The prevalence
of erectile dysfunction in this group was 34%. The postoper-
ative improvement in terms of back and lower limb pain did
not correlate with improvement in terms of erectile dysfunc-
tion. One of the identified risk factors for erectile dysfunction
at six months postoperatively was a North American Spine
Society (NASS) neurogenic symptom score of >70, which may
be a reflection of more permanent neurologic dysfunction re-
sulting from lumbar spine stenosis.
Complications
A study that was presented during the past year examined the use
of large doses of tranexamic acid to decrease blood loss during
complex spinal surgery. This retrospective comparison study
assessed the efficacy and safety of tranexamic acid for non-
pediatric patients undergoing posterior spinal corrective surgery.
Twenty-six patients received large doses of tranexamic acid, and
thirty-three patients did not receive tranexamic acid. There were
no significant differences between the two groups in terms of
demographic or surgical traits. The tranexamic acid group had
significantly less blood loss compared with the control group
and required less blood transfusions during surgery.
Another study on complications examined disc puncture
and injection performed with discography as a potential cause
of lumbar disc damage. In this study, seventy-five patients who
had undergone provocative discography were compared with
seventy-five control patients. The two groups were matched at
baseline with regard to MRI findings and other clinical and de-
mographic features. At ten years of follow-up, fifty-seven patients
in the discography group and fifty-three patients in the control
group had completed all evaluations. There were sixteen lumbar
spine surgical procedures in the discography group, compared
with four in the control group. The use of CT and MRI studies
was more frequent in the discography group. The discography
group also had more adverse events that increased over time.
Events included serious episodes of low back pain, work loss,
medical care visits, and increased medical utilization costs.
Evidence-Based Orthopaedics
Over the past year, the editorial staff of The Journal reviewed a
large number of recently published research studies related to the
musculoskeletal system that received a Level of Evidence grade
of I. Over 100 medical journals were reviewed to identify these
articles, which all have high-quality study design. In addition to
the articles already cited in this Update, twenty-six level-I articles
were identified that were relevant to spine surgery. A list of these
titles is appended to this review following the standard bibliog-
raphy. We have provided a brief commentary about each of these
articles to help to guide your further reading, in an evidence-
based fashion, in this subspecialty area.
Upcoming Meetings and Events Related to Spine Surgery
The Forty-seventh Annual Meeting of the Scoliosis Research
Society (SRS) will be held on September 5 through 8, 2012, in
Chicago, Illinois. Web site: www.srs.org
The EuroSpine annual meeting will be held on October 2
through 4, 2013 in Liverpool, United Kingdom. Web site:
www.eurospine.org
The Twenty-seventh Annual Meeting of the North
American Spine Society (NASS) will be held on October 24
through 27, 2012, in Dallas, Texas. Web site: www.spine.org
The Fortieth Annual Meeting of the Cervical Spine Re-
search Society (CSRS) will be held on December 6 through 8,
2012, in Chicago, Illinois. Web site: www.csrs.org
The Annual Meeting of the American Association of
Neurological Surgeons/Congress of Neurological Surgeons
(AANS/CNS) Section on Disorders of the Spine and Peripheral
Nerves will be held on March 6 through 9, 2013, in Phoenix,
Arizona. Web site: http://spinesection.org
The Federation of Spine Associations will present
the spine program at Specialty Day at the Annual Meeting
of the American Academy of Orthopaedic Surgeons (AAOS)
on March 23, 2013, in Chicago, Illinois. Web site: www.
aaos.org
The Thirteenth Annual Meeting of the International
Society for the Advancement of Spine Surgery (ISASS) will
be held on April 2 through 5, 2013, in Vancouver, British
Columbia, Canada. Web site: www.isass.org
The Thirty-ninth Annual Meeting (Fortieth Anniver-
sary) of the American Spinal Injury Association (ASIA) will be
held on May 6 through 8, 2013, in Chicago, Illinois. Web site:
www.asia-spinalinjury.org
The Annual Meeting of the International Society for the
Study of the Lumbar Spine (ISSLS) will be held on May 13
through 17, 2013, in Scottsdale, Arizona. Web site:
www.issls.org
The Twentieth Annual Meeting of the International
Meeting on Advanced Spine Techniques (IMAST) will be held
on July 10 through 13, 2013, in Vancouver, British Columbia,
Canada. Web site: www.imastonline.com
NOTE: The authors thank Drs. Michael Daubs, Chris Kepler, Steve Mardjetko, K. Daniel Riew, and
Harvinder Sandhu for peer-reviewing the sections of this manuscript.
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Artus M, van der Windt DA, Jordan KP, Hay EM. Low back pain symptoms
show a similar pattern of improvement following a wide range of primary care
treatments: a systematic review of randomized clinical trials. Rheumatology
(Oxford). 2010;49:2346-56. Epub 2010 Aug 16.
Putative treatments for nonspecific low back pain are abundant. This
meta-analysis showed that nonspecific low back pain symptoms seem to de-
crease in a similar pattern in clinical trials of active and inactive treatments,
highlighting the prevalence of a placebo effect in these trials.
Berg S, Tropp HT, Leivseth G. Disc height and motion patterns in the lumbar
spine in patients operated with total disc replacement or fusion for discogenic
back pain. Results from a randomized controlled trial. Spine J. 2011;11:991-8.
Epub 2011 Oct 5.
Using a precise method, distortion-compensated Roentgen analysis
(DCRA), the investigators measured index and adjacent-level motion segments
before and two years after lumbar fusion and intervertebral disc arthroplasty. At
two years, 70% of patients in the fusion group had no motion whereas 85% of
patients in the arthroplasty group had motion. At the adjacent segments, more
anteroposterior translation and angular motion occurred in patients in the
fusion group as compared with the arthroplasty group. None of these radio-
graphic findings were associated with differences in clinical outcome.
Cheng L, Nie L, Li M, Huo Y, Pan X. Superiority of the Bryan disc prosthesis
for cervical myelopathy: a randomized study with 3-year followup. Clin Orthop
Relat Res. 2011;469:3408-14. Epub 2011 Oct 14.
In this prospective study in which the Bryan disc replacement prosthesis
was compared with traditional anterior cervical discectomy and fusion in pa-
tients with cervical myelopathy, the Bryan prosthesis was an effective treatment.
Although the duration of follow-up was three years, the size of the study and
the duration of follow-up were not sufficient to make conclusions regarding
adjacent-segment degeneration.
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Daubs MD, Patel AA, Willick SE, Kendall RW, Hansen P, Petron DJ, Brodke
DS. Clinical impression versus standardized questionnaire: the spinal surgeon’s
ability to assess psychological distress. J Bone Joint Surg Am. 2010;92:2878-83.
Epub 2010 Nov 12.
This article won the ‘‘best paper’’ award at the Scoliosis Research Society
annual meeting in the past. The authors commented that 64% of patients
presenting for spine evaluation have some level of psychological distress. This
may impact the outcome of surgical treatment. The study did not help answer
whether the psychological distress is primary or secondary.
Delamarter R, Zigler JE, Balderston RA, Cammisa FP, Goldstein JA, Spivak
JM. Prospective, randomized, multicenter Food and Drug Administration in-
vestigational device exemption study of the ProDisc-L total disc replacement
compared with circumferential arthrodesis for the treatment of two-level
lumbar degenerative disc disease: results at twenty-four months. J Bone Joint
Surg Am. 2011;93:705-15. Epub 2011 Mar 11.
In this prospective randomized trial, a lumbar intervertebral disc ar-
throplasty device was compared with fusion at two levels in the lumbar spine after
two years of follow-up. Both groups had significant improvement from baseline
ODI scores, and the arthroplasty group had significantly better results in terms of
mean percentage improvement. The arthroplasty group also had better SF-36
physical scores, better visual analog scores for satisfaction, and less narcotic usage.
Engbert K, Weber M. The effects of therapeutic climbing in patients with
chronic low back pain: a randomized controlled study. Spine (Phila Pa 1976).
2011;36:842-9.
This was a prospective randomized study of twenty-eight patients with
chronic low back pain who underwent a four-week program of either a ther-
apeutic climbing regimen or a standard exercise program. The study results
showed comparable outcomes between the two groups, with the exception that
the therapeutic climbing group had better improvements in two of the sub-
scales of the SF-36 (perceived health and physical functioning). The study
showed that therapeutic climbing is equivalent and partly superior to standard
exercise therapy for patients with chronic low back pain.
Garrido BJ,Wilhite J, NakanoM, Crawford C, Baldus C, Riew KD, Sasso RC.
Adjacent-level cervical ossification after Bryan cervical disc arthroplasty com-
pared with anterior cervical discectomy and fusion. J Bone Joint Surg Am.
2011;93:1185-9.
This Level-I clinical trial showed that, after four years of follow-up, pa-
tients who had been managed with cervical disc arthroplasty had a lower inci-
dence of adjacent-level ossification than patients who had been managed with
arthrodesis and plate fixation. The clinical relevance of this finding is unclear.
Gatti R, Faccendini S, Tettamanti A, Barbero M, Balestri A, Calori G. Efficacy
of trunk balance exercises for individuals with chronic low back pain: a ran-
domized clinical trial. J Orthop Sports Phys Ther. 2011;41:542-52. Epub 2011 Jun 7.
This randomized clinical trial included seventy-nine patients with
chronic low back pain who underwent either trunk balance and flexibility
exercises or trunk flexibility exercises alone. Patients who underwent both
balance and flexibility training demonstrated superior results with respect to
Roland-Morris Questionnaire scores and SF-12 physical component summary
scores. These results should be interpreted with caution, however, as the in-
terventions only lasted five weeks.
Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone im-
proves postoperative pain control in patients undergoing complex spine sur-
gery. Anesth Analg. 2011;112:218-23. Epub 2010 Apr 24.
In this prospective randomized study, patients who received methadone
before surgical incision were compared with those who received a continuous
infusion of sufentanil. The single bolus of methadone seemed to decrease post-
operative pain for patients undergoing complex spine surgery. A substantial
limitation of this study was that only twenty-nine patients were enrolled.
Grunnesjo¨ MI, Bogefeldt JP, Blomberg SI, Strender LE, Sva¨rdsudd KF. A
randomized controlled trial of the effects of muscle stretching, manual therapy
and steroid injections in addition to ‘stay active’ care on health-related quality
of life in acute or subacute low back pain. Clin Rehabil. 2011;25:999-1010. Epub
2011 Aug 10.
Patients with acute or subacute low back pain responded best to mul-
timodality therapy in addition to ‘‘stay active’’ care. The results were significant
in a ten-week trial.
Iles R, Taylor NF, Davidson M, O’Halloran P. Telephone coaching can in-
crease activity levels for people with non-chronic low back pain: a randomised
trial. J Physiother. 2011;57:231-8.
In this small randomized controlled study, standard physical therapy
was compared with standard physical therapy plus telephone coaching aimed to
improve exercise. The addition of telephone coaching significantly improved
function and recovery expectations.
Jawahar A, Cavanaugh DA, Kerr EJ 3rd, Birdsong EM, Nunley PD. Total disc
arthroplasty does not affect the incidence of adjacent segment degeneration in
cervical spine: results of 93 patients in three prospective randomized clinical
trials. Spine J. 2010;10:1043-8. Epub 2010 Sep 24.
Ninety-three patients were randomized to either anterior cervical
discectomy and fusion (n = 34) or total disc arthroplasty (n = 59). This
comparative study demonstrated that total disc arthroplasty was equivalent to
anterior cervical discectomy and fusion for providing relief of symptoms.
Furthermore, the risk of developing adjacent-disc segment degeneration was
equivalent after both procedures but was significantly greater for patients who
had concurrent substantial disc degeneration of the lumbar spine.
Jensen C, Jensen OK, Christiansen DH, Nielsen CV. One-year follow-up
in employees sick-listed because of low back pain: randomized clinical trial
comparing multidisciplinary and brief intervention. Spine (Phila Pa 1976).
2011;36:1180-9.
The number of sick leave days due to low back pain was compared
between a multidisciplinary hospital-based intervention and a brief advice
session with a rehabilitation physician and a physical therapist in this ran-
domized clinical trial. The authors found no difference in terms of return to
work or in terms of other outcome measures, leading them to suggest that brief
interventions may offer similar results with less cost and commitment on the
part of both patients and physicians.
Lafage V, Schwab F, Vira S, Patel A, Ungar B, Farcy JP. Spino-pelvic pa-
rameters after surgery can be predicted: a preliminary formula and validation of
standing alignment. Spine (Phila Pa 1976). 2011;36:1037-45.
To predict postoperative spinopelvic parameters (pelvic tilt and sagittal bal-
ance) after deformity correction in adult patients, a set of predictive criteria was
developed with use of regression analysis. These criteria were then used to predict the
pelvic tilt and sagittal balance for a prospective cohort undergoing surgery. The study
demonstrated that pelvic tilt could be predicted from a combination of parameters:
pelvic incidence, maximal lordosis, and maximal kyphosis. The sagittal balance could
be predicted from the same parameters in addition to the predicted pelvic tilt.
Lee JH, Lee SH. Comparison of clinical effectiveness of cervical transforaminal
steroid injection according to different radiological guidances (C-arm fluo-
roscopy vs. computed tomography fluoroscopy). Spine J. 2011;11:416-23.
This prospective, randomized study compared the use of CT fluoros-
copy with regular fluoroscopy for the administration of transforaminal cervical
epidural injections in patients with cervical disc herniations. The authors
concluded that the use of CT fluoroscopy was superior because of better im-
provements in arm pain scores and functional status, with fewer complications.
Masiero S, Bonaldo L, Pigatto M, Lo Nigro A, Ramonda R, Punzi L. Reha-
bilitation treatment in patients with ankylosing spondylitis stabilized with
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tumor necrosis factor inhibitor therapy: a randomized controlled trial.
J Rheumatol. 2011;38:1335-42. Epub 2011 Apr 1.
This randomized controlled trial of sixty-two patients with ankylosing
spondylitis who were receiving anti-TNF(tumor necrosis factor) agents dem-
onstrated that a rehabilitation program combined with an educational/be-
havioral program was more effective than either the educational/behavioral
program alone or no additional therapy for controlling spinal pain and pre-
serving chest and spine range of motion.
Memtsoudis SG, Vougioukas VI, Ma Y, Gaber-Baylis LK, Girardi FP. Peri-
operative morbidity and mortality after anterior, posterior, and anterior/pos-
terior spine fusion surgery. Spine (Phila Pa 1976). 2011;36:1867-77.
In this study from the National Inpatient Sample, the incidence of
procedure-related complications was 18.8% for anterior fusion, 15.7% for
posterior fusion, and 23.8% for anteroposterior fusion. The mortality rate was
approximately half following posterior fusion as compared with anteroposte-
rior fusion (0.26 ± 0.01 versus 0.51 ± 0.04).
Morris S, Morris TP, McGregor AH, Dore´ CJ, Jamrozik K. Function after
spinal treatment, exercise, and rehabilitation: cost-effectiveness analysis based
on a randomized controlled trial. Spine (Phila Pa 1976). 2011;36:1807-14.
The cost-effectiveness of four postoperative treatment groups (reha-
bilitation only, booklet only, rehabilitation plus booklet, or usual care only) was
compared. No treatment proved more cost-effective using commonly accepted
thresholds.
Podichetty VK, Varley ES, Lieberman I. Calcitonin treatment in lumbar spinal
stenosis: a meta-analysis. Spine (Phila Pa 1976). 2011;36:E357-64.
This meta-analysis of the use of calcitonin for the treatment of lumbar
spinal stenosis demonstrated that there was no statistical evidence that calci-
tonin reduced the symptoms of spinal stenosis. This conclusion was based on
four studies with 255 patients that met inclusion criteria.
Rendant D, Pach D, Lu¨dtke R, Reisshauer A, Mietzner A, Willich SN, Witt
CM. Qigong versus exercise versus no therapy for patients with chronic neck
pain: a randomized controlled trial. Spine (Phila Pa 1976). 2011;36:419-27.
In this randomized controlled trial, 123 patients with chronic neck pain
were managed with either qigong, exercise therapy (eighteen sessions over six
months), or no treatment. The results were similar for both the qigong and
exercise therapy groups, and qigong was more effective than no treatment in
terms of pain scores, neck pain and disability, and SF-36 results.
Staples MP, Kallmes DF, Comstock BA, Jarvik JG, Osborne RH, Heagerty PJ,
Buchbinder R. Effectiveness of vertebroplasty using individual patient data
from two randomised placebo controlled trials: meta-analysis. BMJ. 2011;
343:d3952. doi: 10.1136/bmj.d3952.
This meta-analysis combined data from two previously published ran-
domized controlled trials comparing vertebroplasty with placebo treatment. The
study failed to show that vertebroplasty had any benefit in comparison with a
placebo procedure with respect to outcome measures at one month after surgery,
including pain scores, Roland-Morris questionnaire scores, and narcotic usage.
Suri P, Rainville J, Kalichman L, Katz JN. Does this older adult with lower
extremity pain have the clinical syndrome of lumbar spinal stenosis? JAMA.
2010;304:2628-36.
Spinal stenosis is often a clinical diagnosis. The absence of pain when
seated and improvement of symptoms when bending forward are the most
useful individual clinical findings to predict the diagnosis of spinal stenosis in
patients with lower extremity pain.
Tosteson AN, Tosteson TD, Lurie JD, Abdu W, Herkowitz H, Andersson G,
Albert T, Bridwell K, Zhao W, Grove MR, Weinstein MC, Weinstein JN.
Comparative effectiveness evidence from the spine patient outcomes research
trial: surgical versus nonoperative care for spinal stenosis, degenerative spon-
dylolisthesis, and intervertebral disc herniation. Spine (Phila Pa 1976).
2011;36:2061-8.
The costs and quality-adjusted life years (QALYs) were calculated at
four years of follow-up of patients who had undergone operative or nonop-
erative treatment for disc herniation, spinal stenosis, and spondylolisthesis. The
number of QALYs gained was greater in all three surgically treated groups and
the cost per QALY gained was $59,000, $64,300, and $20,600 for the patients
with spinal stenosis, spondylolisthesis, and disc herniation, respectively. The
surgical treatments proved cost-effective for three defined groups.
Umeta RS, Avanzi O. Techniques of lumbar-sacral spine fusion in spondylosis:
systematic literature review and meta-analysis of randomized clinical trials.
Spine J. 2011;11:668-76. Epub 2011 Jun 8.
This systematic review included eight studies that examined perioper-
ative and postoperative outcomes associated with various surgical interventions
for lumbar-sacral spondylosis. The study demonstrated that patients who un-
derwent interbody fusion had less blood loss and higher fusion rates, whereas
those who underwent posterolateral fusion had shorter operative times and
fewer complicationsPage: 35. The wide variety of indications for surgical
treatment with lumbar-sacral fusion makes the interpretation and generaliza-
tion of these results problematic.
van Middendorp JJ, Hosman AJ, Donders AR, Pouw MH, Ditunno JF Jr,
Curt A, Geurts AC, Van de Meent H; EM-SCI Study Group. A clinical
prediction rule for ambulation outcomes after traumatic spinal cord
injury: a longitudinal cohort study. Lancet. 2011;377:1004-10. Epub 2011
Mar 4.
In order to assist clinicians in setting realistic rehabilitation goals and to
provide better prognostic information to patients, logistic regression was used
to build a model based on early physical examination attributes to predict the
potential for ambulation. The final model included such variables as age, motor
strength of the quadriceps and gastrocnemius-soleus muscles, and light touch
sensation in the L3 and S1 dermatomes.
Walker BF, French SD, Grant W, Green SA. Cochrane review of combined
chiropractic interventions for low-back pain. Spine (Phila Pa 1976). 2011;
36:230-42.
This Cochrane systematic review of randomized controlled trials was
performed to determine the effects of chiropractic interventions on adults with
low back pain. The review included twelve studies involving 2887 participants.
The authors concluded that chiropractic interventions led to slight improve-
ment in terms of pain and disability in the short term, and improvement in
terms of pain in the intermediate term, for both acute and subacute low back
pain. There was no evidence to support or refute that these interventions
provide any clinical meaningful difference for pain or disability for low back
pain compared with other interventions.
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